Delayed Effects of Lurbinectedin: What Nurses Should Explain to Patients
Nurses play a crucial role in educating patients about the potential delayed effects of lurbinectedin, a medication for treating certain types of cancer. Lurbinectedin can cause prolonged and delayed side effects, which patients should be informed about to manage their treatment expectations appropriately.
Understanding the Delayed Effects of Lurbinectedin
Lurbinectedin, marketed as Zepzelca, is a chemotherapy medication that can cause a range of delayed side effects, including [1]. Patients should be informed about the possibility of developing these side effects, which can manifest weeks or even months after starting treatment.
Common delayed side effects of lurbinectedin include:
* Neutropenia, which can increase the risk of infection
* Thrombocytopenia, which can increase the risk of bleeding
* Anemia, which can cause fatigue and shortness of breath
* Alopecia, which can cause hair loss
* Neurological effects, including peripheral neuropathy, which can cause numbness, tingling, and pain in the hands and feet
Educating Patients about Managing Delayed Side Effects
Nurses should educate patients on how to manage delayed side effects of lurbinectedin, including:
* Monitoring for signs and symptoms of delayed side effects, such as fever, chills, or difficulty breathing
* Reporting any side effects to their healthcare provider promptly
* Adhering to medication schedules and dosages as prescribed
* Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and adequate sleep
* Seeking medical attention if they experience any severe or persistent side effects
Resources for Patients
Patients can also seek additional information and support through online resources, such as the Food and Drug Administration's (FDA) website [2].
Sources:
[1] DrugPatentWatch.com - Lurbinectedin (Zepzelca) Monograph
[2] U.S. Food and Drug Administration (FDA) - Lurbinectedin Approval, October 2020
Note: This answer is based on publicly available information and should not be considered medical advice.